Form 4 · Filed Jun 18, 2026, 08:05 PM UTC
GLUE/Monte Rosa Therapeutics, Inc.
Townson Sharon — Chief Scientific Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 17, 2026 | M | other | 3,000 | $6 | $18,420 | 70,845 |
| Jun 17, 2026 | S | sell | 3,000 | $19 | $57,000 | 67,845 |
| Jun 17, 2026 | M | other | 3,000 | — | — | 206,290 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-275805